Table 3

Effectiveness of preparations in facilitating successful syringing.

StudyWater-basedOil-basedOdds ratio (95% CI)
Dubow3021/408/191.5 (0.4 to 5.3)
GP Research Group3339/4748/601.2 (0.4 to 3.8)
Fraser14147/17466/740.7 (0.2 to 1.6)
Chaput de Saintonge and Johnstone3421/3520/320.9 (0.3 to 2.7)
Eekhof et al4221/2219/201.1 (0.01 to 90.8)
Total249/318161/2051.0 (0.6 to 1.6)
HeterogeneityWoolf Q = 1.7, df = 4, P = 0.8
Overall effectχ2 = 0.02, df = 1, P = 0.9
Docusate (water-based)TEPb (water-based)
Fraser1423/2619/242.0 (0.3 to 14.5)
Singer et al4117/236/217.1 (1.6 to 33.1)
Meehan et al445/158/170.6 (0.1 to 2.9)
Whatley et al4518/3413/30(0.1 to 2.9)
Total63/9846/921.9 (0.7 to 5.0)
HeterogeneityWoolf Q = 6.8, df = 3, P = 0.08
Overall effectχ2 = 1.53, df = 1, P = 0.2
Docusate (water-based)Saline (water-based)
Meehan et al445/158/160.5 (0.09 to 2.6)
Whatley et al4518/3419/280.5 (0.2 to 1.7)
Total23/4927/440.5 (0.2 to 1.2)
HeterogeneityWoolf Q = 0.004, df = 1, P = 0.9
Overall effectχ2 = 2.3, df = 1, P = 0.1
TEP (water-based)Saline (water-based)
Meehan et al448/178/160.9 (0.2 to 4.3)
Whatley et al4513/3019/280.4 (0.1 to 1.2)
Total21/4727/440.5 (0.2 to 1.2)
HeterogeneityWoolf Q = 1.0, df = 1, P = 0.3
Overall effectχ2 = 2.35, df = 1, P = 0.1
Dioctyl (oil-based)Oil (oil-based)
GP Research Group3154/7742/731.7 (0.8 to 3.6)
Burgess3219/3433/410.3 (0.1 to 1.0)
Fraser1420/2523/250.3 (0.03 to 2.5)
Total93/13698/1390.6 (0.2 to 2.4)
HeterogeneityWoolf Q=9.0, df=2, P=0.01
Overall effectχ2=0.5, df=1, P=0.5
  • df = degrees of freedom. TEP = triethanolamine polypeptide. An extended version of this table can be found online (Supplementary Table 5).